As the field evolves, its crucial for healthcare leaders and organizations to stay agile, adapt to new trends, and focus on what matters most for patients and providers, namely: GLP1s are now firstline therapies: Adoption has accelerated from just 3% in 2021 to more than 23% in 2025, displacing longstanding generics like metformin
Should You Stop Taking GLP-1 Injections Because of Hair Loss
Who is a good candidate for glp-1
Retatrutide is started low and increased gradually to reduce side effects, so full appetite suppression only kicks in once you reach your maintenance dose
Always disclose your full medical history to your provider before starting
Avoid harsh exfoliants, alcohol-based products, or heavily fragranced cosmetics that may irritate sensitive skin